12:00 AM
Oct 13, 2008
 |  BC Week In Review  |  Company News  |  Other News

Ranbaxy news

The U.S. Department of Justice withdrew its motion to enforce subpoenas related to an investigation of Ranbaxy's alleged introduction of adulterated and misbranded products into interstate commerce. In...

Read the full 120 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >